COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 179 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $323 | -17.4% | 10,035 | -0.5% | 0.00% | 0.0% |
| Q1 2024 | $391 | -8.4% | 10,083 | -27.3% | 0.00% | 0.0% |
| Q4 2023 | $427 | +19.6% | 13,870 | -13.2% | 0.00% | 0.0% |
| Q3 2023 | $357 | +5.3% | 15,971 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $339 | -7.6% | 15,791 | +3.3% | 0.00% | 0.0% |
| Q1 2023 | $367 | -3.4% | 15,282 | -6.6% | 0.00% | 0.0% |
| Q4 2022 | $380 | -99.9% | 16,369 | -1.1% | 0.00% | 0.0% |
| Q3 2022 | $265,000 | -8.9% | 16,544 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $291,000 | -15.2% | 16,398 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $343,000 | -48.8% | 16,849 | -53.1% | 0.00% | +50.0% |
| Q4 2021 | $670,000 | +82.6% | 35,894 | +92.8% | 0.00% | -33.3% |
| Q3 2021 | $367,000 | -18.1% | 18,617 | -1.7% | 0.00% | -25.0% |
| Q2 2021 | $448,000 | – | 18,933 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $32,405,000 | 8.36% |
| SECTORAL ASSET MANAGEMENT INC | 1,156,934 | $19,865,000 | 2.70% |
| 1492 Capital Management LLC | 150,189 | $2,579,000 | 2.31% |
| Eventide Asset Management | 2,207,610 | $37,905,000 | 1.68% |
| J. Goldman & Co LP | 1,066,847 | $18,318,000 | 1.41% |
| HAMILTON LANE ADVISORS LLC | 89,975 | $1,545,000 | 1.35% |
| Rock Springs Capital Management LP | 1,605,105 | $27,560,000 | 1.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 932,126 | $16,005,000 | 0.58% |
| Opaleye Management Inc. | 80,000 | $1,373,000 | 0.51% |
| Cortina Asset Management, LLC | 456,036 | $7,830,000 | 0.48% |